Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and… EP News Bureau Jun 18, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa Capsules, 75 mg, 110 mg, and…
